2-Butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile

Catalog No. :
ACNEWI929
CAS No. :
673435-88-6
Molecular Formula :
C27H31N5
Molecular Weight :
425.58

IUPAC Name:2-butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile

2-Butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
IUPAC Name2-butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
Molecular FormulaC27H31N5
Molecular Weight425.58
SMILESCCCCC1=C(C)C(C#N)=C2NC3=CC=CC=C3N2C1=NC1=CC=C(N(CC)CC)C=C1
InChI KeyXKASPANWLDZMPG-UHFFFAOYSA-N
Synonym(E)-2-butyl-1-((4-(diethylamino)phenyl)imino)-3-methyl-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile;Pyrido[1,2-a]benzimidazole-4-carbonitrile, 2-butyl-1-[[4-(diethylamino)phenyl]imino]-1,5-dihydro-3-methyl-
CAS No.673435-88-6

Synthetic Route by SureRoute

1. ACNEWI929 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRYFV023 route compound structure diagram
    ACRYFV02393-05-0 In Stock
  4. Then
  5. ACNEWI929 route product structure diagram
    ACNEWI929673435-88-6
Inquiry

2. ACNEWI929 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRYFV023 route compound structure diagram
    ACRYFV02393-05-0 In Stock
  4. Then
  5. ACNEWI929 route product structure diagram
    ACNEWI929673435-88-6
Inquiry

Comments (0)